Search Details

Word: research (lookup in dictionary) (lookup stats)
Dates: during 1990-1999
Sort By: most recent first (reverse)


Usage:

...growing salaries of university presidents seem to be excessive," said Ernst Benjamin, director of research for the American Association of University Professors. "It seems to reflect what is going on in corporations, and, while universities do have similar responsibilities, they are also a charity organization...

Author: By Sarah A. Dolgonos, CONTRIBUTING WRITER | Title: Rudenstine's Salary Below College Median | 11/23/1999 | See Source »

...with many other projects, things have gone a bit more slowly than we expected with the portals," wrote Paul C. Martin, dean for research and information technology, in an e-mail message...

Author: By Shira H. Fischer, CONTRIBUTING WRITER | Title: Web Portals Delayed Six Weeks | 11/23/1999 | See Source »

Clinical trials are research studies on human patients to test the safety and effectiveness of new treatments. There are hundreds of clinical cancer trials under way, involving thousands of patients. What most people don't realize is that the scientists who conduct these studies need test subjects almost as badly as the subjects need treatment, and that lately the scientists have been running short of willing participants. At a conference on clinical trials held recently in Alexandria, Va., researchers trying to devise strategies for signing up more patients noted that one of the reasons there has been so much progress...

Author: /time Magazine | Title: How to Find a Trial | 11/22/1999 | See Source »

...true that research scientists don't always have the best bedside manner, and sometimes they unnecessarily keep patients in the dark. And the consent forms are often so encrusted with medical jargon that some patients joke they would rather take their chances with cancer than fill them...

Author: /time Magazine | Title: How to Find a Trial | 11/22/1999 | See Source »

Schering-Plough argues that additional patent years are only fair. Claritin was stuck in the Food and Drug Administration approval pipeline longer than many drugs, it claims, with the clock ticking on its 17-year patent. Schering-Plough also says Claritin profits help fund research for new drugs. But, its opponents counter, what about Claritin patients--who pay as much as $2.66 a dose instead of the 50[cents] or less they would pay, analysts figure, if a generic version of the drug were available? If the patent expires on time, according to a University of Minnesota study funded...

Author: /time Magazine | Title: The Claritin Case | 11/22/1999 | See Source »

Previous | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | Next